Earnings Call · Q4 FY2022·2023-01-24

Q4 22EPS +9.57%·Rev n/aQ3 22EPS +22.34%·Rev n/aQ2 22EPS +25.44%·Rev n/aQ1 22EPS +18.49%·Rev n/a⚠ consensus missing

ABBOTT LABORATORIES ABT

Scott Leinenweber — Vice President, Investor Relations

Robert Ford — Chairman and Chief Executive Officer

Robert Funck — Executive Vice President, Finance and Chief Financial Officer

−1.4%1d on move date−1.4% vs SPY3d−2.3%5d−1.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABT calls or request research access.

More ABT calls Browse calls Request research access